Relapsing polychondritis

Rheum Dis Clin North Am. 2013 May;39(2):263-76. doi: 10.1016/j.rdc.2013.03.002.

Abstract

Relapsing polychondritis (RP) is a rare systemic autoimmune disease characterized by episodic, progressive inflammatory destruction of cartilage. It can occur as an overlap syndrome in patients with other rheumatologic conditions. The disease usually follows an indolent relapsing-remitting course, but occasionally it can progress rapidly and even cause death. Although auricular or nasal chondritis or peripheral arthritis without other significant organ involvement are usually treated with low-dose corticosteroids, other more severe disease manifestations may require treatment with high-dose corticosteroids or other immunosuppressive agents. Biological targeted therapies might prove to be effective treatments of this condition.

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Arthritis, Rheumatoid / epidemiology*
  • Comorbidity
  • Ear Cartilage / pathology
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Molecular Targeted Therapy
  • Myelodysplastic Syndromes / epidemiology*
  • Polychondritis, Relapsing* / drug therapy
  • Polychondritis, Relapsing* / epidemiology
  • Polychondritis, Relapsing* / pathology
  • Spondylarthropathies / epidemiology*
  • Vasculitis / epidemiology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • Immunosuppressive Agents
  • tocilizumab